Size distribution of fullerenol nanoparticles in cell culture medium and their influence on antioxidative enzymes in Chinese hamster ovary cells;Raspodela fulerenolskih nanočestica po veličini u ćelijskom medijumu i njihov uticaj na antioksidativne enzime u ovarijalnim ćelijama kineskog hrčka

Hemijska Industrija

Volumn 69, Issue 4, 2015, Pages 425-431

  Srdjenovic, Branislava U ^a   Slavić, Marija N ^b   Stankov, Karmen M ^a   Kladar, Nebojša V ^a   Jović, Danica S ^a   Seke, Mariana N ^c   Bogdanović, Višnja V ^d  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Institute of Oncology Sremska Kamenica   (Yugoslavia)

Author keywords

Antioxidative enzyme; CHO K1 cell line; Fullerenol; Mytomocine C

Indexed keywords

EID: 84939787369     PISSN: 0367598X     EISSN: 22177426     Source Type: Journal    
DOI: 10.2298/HEMIND131218054S     Document Type: Article

References (32)

1. S. Wilson, D. Schuster, M. Maggini M. Prato, R. Taylor, in K.M. Kadish, R.S. Ruoff (Eds.), Organic chemistry of fullerenes, Wiley-Interscience, New York, 2000, pp. 91-177.
2. 60 fullerol, Adv. Funct. Mater. 16 (2006) 120-128.
3. J.A. Brant, C.O. Robichaund, M. Wiesner, Fullerol cluster formation in aqueous solutions: Implications for environmental release, J. Colloid Interface Sci. 314 (2007) 281-288.
4. 22 on doxorubicin-induced cytotoxicity, Toxicol. In Vitro 18 (2004) 629-637.
5. 24, Oxid. Commun. 27 (2005) 213-218.
6. J. Grebowski, P. Kazmierska, A. Krokosz, Fullerenols as a New Therapeutic Approach in Nanomedicine, Biomed. Res. Int. (2013), DOI: 10.1155/2013/751913.
7. J.J. Yin, F. Lao, P.P. Fu, W.G. Wamer, Y. Zhao, P.C. Wang, Y. Qiu, B. Sun, G. Xing, J. Dong, X-J. Liang, C. Chen, The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials, Biomaterials 30 (2009) 611-621.
8. 24 on the frequency of micronuclei and chromosome aberrations in CHO-K1 cells, Mutat. Res: Genet. Toxicol. Environ. Mutagen 680 (2009) 25-30.
9. 24 effects on antioxidative enzymes activity in irradiated human erythroleukemia cell line, J. Radiat. Res. 49 (2008) 321-327.
10. 24 and amifostine in irradiated rats, Colloids Surfaces, B 58 (2007) 39-43.
11. 24, Toxicol. Mech. Methods 19 (2009) 24-28.
12. 24 prevents doxorubicin-induced acute cardiotoxicity in rats, Pharmacol. Rep. 62 (2010) 707-718.
13. 24 in rat kidneys, testes, and lungs treated with doxorubicin, Toxicol. Mech. Meth. 20 (2010) 298-305.
14. I. Icevic, S. Vukmirovic, B. Srdjenovic, J. Sudji, A. Djordjevic, R. Injac, V. Vasović, Protective effects of orally applied fullerenol nanoparticles in rats after a single dose of doxorubicin, Hem. Ind. 65 (2011) 329-337.
15. 24 in doxorubicin- induced hepatotoxicity in rats with mammary carcinomas, Biomaterials 29 (2008) 3451-3460.
16. 24 via suppression of oxidative stress, Pharmacol. Rep. 60 (2008) 742-749.
17. 24 trough inhibition of oxidative stress, Pharmacol. Rep. 61 (2009) 335-342.
18. 24 against doxorubicin- induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer, Biomaterials 30 (2009) 1184-1196.
19. L.Yan, Z. Gu, Y. Zhao, Chemical mechanisms of the toxicological properties of nanomaterials: generation of intracellular reactive oxygen species, Chem. Asian J. 10 (2013) 2342-2353.
20. D. Siegel, H. Beall, C. Senekowitsch, M. Kasai, H. Arai, N. Gibson, D. Ross, Bioreductive activation of mitomycin C by DT-diaphorase, Biochemistry 31 (1992) 7879-7885.
21. 24, Fullerene Sci. Technol. 6 (1998) 689-694.
22. M.C. Black, B. Berenbaum, Factors affecting the dye exclusion test for cell viability, Exp. Cell. Res. 3 (1985) 9-13.
23. H.P. Mishra, I. Fridovich, The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, J. Biol. Chem. 247 (1972) 3170-3175.
24. E. Beutler, Red Cell Metabolism: A Manual of Biochemical Methods, Grune&Stratton, New York, 1984.
25. 24 on micronuclei and chromosomal aberrations' frequency in peripheral blood lymphocytes, Dig. J. Nanomater. Biostruct. 7 (2012) 673-386.
26. B. Fubini, M. Ghiazza, I. Fenoglio, Physicochemical features of engineered nanoparticles relevant to their toxicity, Nanotoxicology 4 (2010) 347-363.
27. J.G. Saathoff, A.O. Inman, X.R. Xia, J.E. Riviere, N.A. Monteiro-Riviere, In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells, Toxicol. In Vitro 25 (2011) 2105-2112.
28. D. Wink, J. Mitchell, Chemical biology of nitric oxide: Insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide, Free Radic. Biol. Med. 25 (1998) 434-456.
29. 18-22(OK4)), Comp. Biochem. Phys., A 165 (2013) 460-467.
30. S. Ye, M. Chen, Y. Jiang, M. Chen, T. Zhou, Y. Wang, Z. Hou, L. Ren, Polyhydroxylated fullerene attenuates oxidative stress-induced apoptosis via a fortifying Nrf2-regulated cellular antioxidant defence system. Int. J. Nanomed. 9 (2014) 2073-2087.
31. 24, Afr. J. Biotechnol. 7 (2008) 4050-4940.
32. V.M. Torres, B. Srdjenovic, in: R.F.Verner, C. Benvegnu (Eds.), Handbook on Fullerene: Synthesis, Properties and Applications, Nova Science Publishers, Inc., Hauppauge, 2012, pp. 197-238.